Human medicines European public assessment report (EPAR): Vaborem, meropenem,vaborbactam, Urinary Tract Infections;Bacteremia;Bacterial Infections;Respiratory Tract Infections;Pneumonia;Pneumonia, Ventilator-Associated, Date of authorisation: 20/11/2018,
|